Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: An international study of 891 patients

Alessandra Carobbio, Juergen Thiele, Francesco Passamonti, Elisa Rumi, Marco Ruggeri, Francesco Rodeghiero, Maria Luigia Randi, Irene Bertozzi, Alessandro M. Vannucchi, Elisabetta Antonioli, Heinz Gisslinger, Veronika Buxhofer-Ausch, Guido Finazzi, Naseema Gangat, Ayalew Tefferi, Tiziano Barbui

Research output: Contribution to journalArticle

Abstract

In an international collaborative study, a central histologic review identified 891 patients with essential thrombocythemia, strictly defined by World Health Organization criteria. After a median follow-up of 6.2 years, 109 (12%) patients experienced arterial (n = 79) or venous (n = 37) thrombosis. In multivariable analysis, predictors of arterial thrombosis included age more than 60 years (P = .03; hazard ratio [HR] = 1.7), thrombosis history (P = .003; HR = 2.1), cardiovascular risk factors including tobacco use, hypertension, or diabetes mellitus (P = .007; HR = 1.9), leukocytosis (> 11 × 10 9/L; P = .04; HR = 1.7), and presence of JAK2V617F (P = .009; HR = 2.6). In contrast, only male gender predicted venous thrombosis. Platelet count more than 1000 × 109/L was associated with a lower risk of arterial thrombosis (P = .007; HR = 0.4). These associations, except the one with leukocytosis, remained significant (or near significant) when analysis was restricted to JAK2V617F-positive cases. The current study clarifies the contribution of specific disease and host characteristics to the risk of arterial versus venous thrombosis in essential thrombocythemia.

Original languageEnglish
Pages (from-to)5857-5859
Number of pages3
JournalBlood
Volume117
Issue number22
DOIs
Publication statusPublished - Jun 2 2011

Fingerprint

Essential Thrombocythemia
Venous Thrombosis
Hazards
Thrombosis
Leukocytosis
Tobacco Use
Platelet Count
Diabetes Mellitus
Tobacco
Medical problems
Platelets
Hypertension
Health

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia : An international study of 891 patients. / Carobbio, Alessandra; Thiele, Juergen; Passamonti, Francesco; Rumi, Elisa; Ruggeri, Marco; Rodeghiero, Francesco; Randi, Maria Luigia; Bertozzi, Irene; Vannucchi, Alessandro M.; Antonioli, Elisabetta; Gisslinger, Heinz; Buxhofer-Ausch, Veronika; Finazzi, Guido; Gangat, Naseema; Tefferi, Ayalew; Barbui, Tiziano.

In: Blood, Vol. 117, No. 22, 02.06.2011, p. 5857-5859.

Research output: Contribution to journalArticle

Carobbio, A, Thiele, J, Passamonti, F, Rumi, E, Ruggeri, M, Rodeghiero, F, Randi, ML, Bertozzi, I, Vannucchi, AM, Antonioli, E, Gisslinger, H, Buxhofer-Ausch, V, Finazzi, G, Gangat, N, Tefferi, A & Barbui, T 2011, 'Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: An international study of 891 patients', Blood, vol. 117, no. 22, pp. 5857-5859. https://doi.org/10.1182/blood-2011-02-339002
Carobbio, Alessandra ; Thiele, Juergen ; Passamonti, Francesco ; Rumi, Elisa ; Ruggeri, Marco ; Rodeghiero, Francesco ; Randi, Maria Luigia ; Bertozzi, Irene ; Vannucchi, Alessandro M. ; Antonioli, Elisabetta ; Gisslinger, Heinz ; Buxhofer-Ausch, Veronika ; Finazzi, Guido ; Gangat, Naseema ; Tefferi, Ayalew ; Barbui, Tiziano. / Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia : An international study of 891 patients. In: Blood. 2011 ; Vol. 117, No. 22. pp. 5857-5859.
@article{412ac734ef614d9cb9e41907813c9d08,
title = "Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: An international study of 891 patients",
abstract = "In an international collaborative study, a central histologic review identified 891 patients with essential thrombocythemia, strictly defined by World Health Organization criteria. After a median follow-up of 6.2 years, 109 (12{\%}) patients experienced arterial (n = 79) or venous (n = 37) thrombosis. In multivariable analysis, predictors of arterial thrombosis included age more than 60 years (P = .03; hazard ratio [HR] = 1.7), thrombosis history (P = .003; HR = 2.1), cardiovascular risk factors including tobacco use, hypertension, or diabetes mellitus (P = .007; HR = 1.9), leukocytosis (> 11 × 10 9/L; P = .04; HR = 1.7), and presence of JAK2V617F (P = .009; HR = 2.6). In contrast, only male gender predicted venous thrombosis. Platelet count more than 1000 × 109/L was associated with a lower risk of arterial thrombosis (P = .007; HR = 0.4). These associations, except the one with leukocytosis, remained significant (or near significant) when analysis was restricted to JAK2V617F-positive cases. The current study clarifies the contribution of specific disease and host characteristics to the risk of arterial versus venous thrombosis in essential thrombocythemia.",
author = "Alessandra Carobbio and Juergen Thiele and Francesco Passamonti and Elisa Rumi and Marco Ruggeri and Francesco Rodeghiero and Randi, {Maria Luigia} and Irene Bertozzi and Vannucchi, {Alessandro M.} and Elisabetta Antonioli and Heinz Gisslinger and Veronika Buxhofer-Ausch and Guido Finazzi and Naseema Gangat and Ayalew Tefferi and Tiziano Barbui",
year = "2011",
month = "6",
day = "2",
doi = "10.1182/blood-2011-02-339002",
language = "English",
volume = "117",
pages = "5857--5859",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "22",

}

TY - JOUR

T1 - Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia

T2 - An international study of 891 patients

AU - Carobbio, Alessandra

AU - Thiele, Juergen

AU - Passamonti, Francesco

AU - Rumi, Elisa

AU - Ruggeri, Marco

AU - Rodeghiero, Francesco

AU - Randi, Maria Luigia

AU - Bertozzi, Irene

AU - Vannucchi, Alessandro M.

AU - Antonioli, Elisabetta

AU - Gisslinger, Heinz

AU - Buxhofer-Ausch, Veronika

AU - Finazzi, Guido

AU - Gangat, Naseema

AU - Tefferi, Ayalew

AU - Barbui, Tiziano

PY - 2011/6/2

Y1 - 2011/6/2

N2 - In an international collaborative study, a central histologic review identified 891 patients with essential thrombocythemia, strictly defined by World Health Organization criteria. After a median follow-up of 6.2 years, 109 (12%) patients experienced arterial (n = 79) or venous (n = 37) thrombosis. In multivariable analysis, predictors of arterial thrombosis included age more than 60 years (P = .03; hazard ratio [HR] = 1.7), thrombosis history (P = .003; HR = 2.1), cardiovascular risk factors including tobacco use, hypertension, or diabetes mellitus (P = .007; HR = 1.9), leukocytosis (> 11 × 10 9/L; P = .04; HR = 1.7), and presence of JAK2V617F (P = .009; HR = 2.6). In contrast, only male gender predicted venous thrombosis. Platelet count more than 1000 × 109/L was associated with a lower risk of arterial thrombosis (P = .007; HR = 0.4). These associations, except the one with leukocytosis, remained significant (or near significant) when analysis was restricted to JAK2V617F-positive cases. The current study clarifies the contribution of specific disease and host characteristics to the risk of arterial versus venous thrombosis in essential thrombocythemia.

AB - In an international collaborative study, a central histologic review identified 891 patients with essential thrombocythemia, strictly defined by World Health Organization criteria. After a median follow-up of 6.2 years, 109 (12%) patients experienced arterial (n = 79) or venous (n = 37) thrombosis. In multivariable analysis, predictors of arterial thrombosis included age more than 60 years (P = .03; hazard ratio [HR] = 1.7), thrombosis history (P = .003; HR = 2.1), cardiovascular risk factors including tobacco use, hypertension, or diabetes mellitus (P = .007; HR = 1.9), leukocytosis (> 11 × 10 9/L; P = .04; HR = 1.7), and presence of JAK2V617F (P = .009; HR = 2.6). In contrast, only male gender predicted venous thrombosis. Platelet count more than 1000 × 109/L was associated with a lower risk of arterial thrombosis (P = .007; HR = 0.4). These associations, except the one with leukocytosis, remained significant (or near significant) when analysis was restricted to JAK2V617F-positive cases. The current study clarifies the contribution of specific disease and host characteristics to the risk of arterial versus venous thrombosis in essential thrombocythemia.

UR - http://www.scopus.com/inward/record.url?scp=79957975519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957975519&partnerID=8YFLogxK

U2 - 10.1182/blood-2011-02-339002

DO - 10.1182/blood-2011-02-339002

M3 - Article

C2 - 21490340

AN - SCOPUS:79957975519

VL - 117

SP - 5857

EP - 5859

JO - Blood

JF - Blood

SN - 0006-4971

IS - 22

ER -